| 11858991
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics. |
Bioorg Med Chem Lett |
2002 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Hou X;Meador JW;Ferre RA;Worland ST |
View
More |
| 11931615
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. |
J Med Chem |
2002 |
Dragovich PS;Prins TJ;Zhou R;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Tuntland T;Lee CA;Patick AK;Matthews DA;Hendrickson TF;Kosa MB;Liu B;Batugo MR;Gleeson JP;Sakata SK;Chen L;Guzman MC;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 14521419
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. |
J Med Chem |
2003 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Hua Y;Luu HT;Sakata SK;Brown EL;Maldonado FC;Tuntland T;Lee CA;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Wu EY;Guo M;Borer BC;Nayyar NK;Moran T;Chen L;Rejto PA;Rose PW;Guzman MC;Dovalsantos EZ;Lee S;McGee K;Mohajeri M;Liese A;Tao J;Kosa MB;Liu B;Batugo MR;Gleeson JP;Wu ZP;Liu J;Meador JW 3rd;Ferre RA |
View
More |
| 28192097
|
Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice. |
Eur J Pharmacol |
2017 |
Khamseekaew J;Kumfu S;Wongjaikam S;Kerdphoo S;Jaiwongkam T;Srichairatanakool S;Fucharoen S;Chattipakorn SC;Chattipakorn N |
View
More |
| 35533446
|
Perampanel enhances the cardiovagal tone and heart rate variability (HRV) in patients with drug-resistant temporal lobe epilepsy. |
Seizure |
2022 |
Dono F;Evangelista G;Consoli S;Rodorigo D;Russo M;Carrarini C;Di Pietro M;De Angelis MV;Faustino M;Anzellotti F;Onofrj M;Di Iorio A;Sensi SL;Frazzini V;Vollono C |
View
More |
| 4799550
|
3-Deazauridine: inhibition of ribonucleic acid virus-induced cytopathogenic effects in vitro. |
Antimicrob Agents Chemother |
1972 |
Shannon WM;Arnett G;Schabel FM Jr |
View
More |
| 9213204
|
Hemodynamic and autonomic effects of intravenous saterinone in patients with chronic heart failure. |
J Cardiovasc Pharmacol |
1997 |
Szabo BM;van Veldhuisen DJ;van Dijk RB;Lahiri A;Mitrovic V;Stolzenburg K;Brouwer J;Lie KI |
View
More |
